Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.
Protein & Cell|September 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitopeZezhong Liu, Wei Xu, Zhenguo Chen, et al.
BMC Biology|October 2, 2023
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination historyAnqi Xia, Xiaojie Wang, Jiaying He, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Nature Communications|November 26, 2025
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolutionMinxiang Xie, Yinong Qiu, Xiaoyu Zhao, et al.
European Journal of Immunology|October 28, 2022
Guidelines for mouse and human DC generationManfred B Lutz, Shafaqat Ali, Cindy Audiger, et al.
Plos One|November 11, 2024
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functionsSedem Dankwa, Christina Kosman, Maria Dennis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodiesCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Research Square|November 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinomaSangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Pageof 35